Schedule 1

Includes drugs with no proven or acceptable medical use and a high abuse potential - authorized research only.

Schedule 2

Includes narcotic drugs with a high potential for abuse but with currently accepted medical use in treatment. (opiates, cocaine, methadone, meperidine)

Schedule 2N

Includes non-narcotic drugs with a high potential for abuse, such as amphetamines, phenmetrazine, methylphenidate, and short-acting barbiturates.

Schedule 3

Includes narcotics in combination with other non-narcotic drugs, such as codeine combined with acetominophen or aspirin, phenacetin, and caffeine.

Schedule 3N

Includes central nervous system depressants, such as glutethimide, methyprylon, and barbiturates not listed in other schedules. Also includes anorectant agents not included in other schedules.

Schedule 4

Includes narcotics in combination with other non-narcotic drugs, antidiarrheals, mild CNS depressants, mild CNS stimulants, and tranquilizers. Drugs such as chloral hydrate, meprobamate, phenobarbital, diphenoxylate with atropine sulfate, chlordiazepoxide, diazepam, diethylpropion and phentermine are in this group.

Schedule 5

Includes narcotic cough syrups and ephedrine, pseudoephedrine, and phenylpropanolamine products.